News & Updates

Treating gout patients with urate-lowering therapy (ULT) to meet a serum urate level below 6 mg/dL within 12 months results in a reduced risk of major adverse cardiovascular events, as shown in a new user cohort study.

In patients with postendoscopic sphincterotomy (post-EST) bleeding, polysaccharide hemostatic powder (PHP) demonstrates noninferiority to endoscopic clip in the management of post-EST bleeding and is easier to use, reports a study.

Among patients with endometrial cancer receiving treatment with pembrolizumab, those with obesity appear to have worse progression-free survival (PFS), according to a retrospective study.

Peptide receptor radionuclide therapy (PRRT) with lutetium-177 (¹⁷⁷Lu)-Dotatate significantly improved progression-free survival (PFS) among Asian patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), according to the LUMINET-1 study presented at ESMO Asia 2025.

In the treatment of uncomplicated urogenital gonorrhoea, a single dose of the novel oral antibiotic zoliflodacin shows similar efficacy and safety profile as the ceftriaxone plus azithromycin combination, as shown in a multinational phase III study.

The market for liver supplements is rapidly growing despite lacking scientific evidence to support their efficacy claims, reveals a study.